Lung antibiotic mystery: COVID-19 may block drugs from reaching infection
NCT ID NCT05464680
First seen Nov 19, 2025 · Last updated May 13, 2026 · Updated 16 times
Summary
This study looked at why antibiotics often fail to treat pneumonia in COVID-19 patients on breathing machines. Researchers measured how much of the antibiotic piperacillin reaches the lung fluid in 34 adults with severe lung injury. The goal was to understand if poor drug penetration explains the high rate of repeat infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service Médecine Intensive Réanimation
Marseille, 13015, France
Conditions
Explore the condition pages connected to this study.